Literature DB >> 11416009

Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.

S V Reddy1, N Kurihara, C Menaa, G Landucci, D Forthal, B A Koop, J J Windle, G D Roodman.   

Abstract

Pagetic osteoclasts (OCLs) are abnormal in size and contain paramyxoviral-like nuclear inclusions that cross-react with antibodies to measles virus (MV). However, the role that MV infection plays in Paget's disease is unknown, because no animal model of Paget's disease is available. Therefore, we targeted a cellular MV receptor, human CD46 (hCD46), to cells in the OCL lineage in transgenic mice using the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. In vitro infection of OCL precursors from hCD46 transgenic mice with MV significantly increased OCL formation in bone marrow cultures. The numbers of TRAP-positive mononuclear cells and CFU-GM, the earliest identifiable OCL precursor, were also significantly increased. MV-infected OCLs formed from hCD46 marrow were increased in size, contained markedly increased numbers of nuclei, and had increased bone-resorbing capacity per OCL compared with OCLs formed from marrow of nontransgenic littermates. Furthermore, IL-6 and 24-hydroxylase messenger RNA expression levels were increased in MV-infected hCD46 transgenic mouse bone marrow cultures. Treatment of MV-infected hCD46 marrow cultures with a neutralizing antibody to IL-6 blocked the increased OCL formation seen in these cultures. These data demonstrate that MV infection of OCL precursors results in OCLs that have many features of pagetic OCLs, that the enhanced OCL formation is in part mediated by increased IL-6 expression induced by MV infection, and suggest that the hCD46 transgenic mouse may be a useful model for examining the effects of MV infection on OCL formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416009     DOI: 10.1210/endo.142.7.8255

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

2.  Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.

Authors:  Srinivasan Shanmugarajan; Rimon F Youssef; Parmita Pati; William L Ries; D Sudhaker Rao; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

3.  Paget's disease population analysis within Rheumatology Outpatient of the ASL of Biella (Piedmont Region, Italy).

Authors:  Lorena Longato
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

4.  Expression of measles virus receptors in otosclerotic, non-otosclerotic and in normal stapes footplates.

Authors:  Tamás Karosi; István Jókay; József Kónya; Mihály Petkó; László Z Szabó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-09       Impact factor: 3.236

Review 5.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31

6.  Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts.

Authors:  Hyunsoo Kim; Kyunghee Lee; Jin Man Kim; Mi Yeong Kim; Jae-Ryong Kim; Han-Woong Lee; Youn Wook Chung; Hong-In Shin; Taesoo Kim; Eui-Soon Park; Jaerang Rho; Seoung Hoon Lee; Nacksung Kim; Soo Young Lee; Yongwon Choi; Daewon Jeong
Journal:  Nat Commun       Date:  2021-04-15       Impact factor: 14.919

Review 7.  Update on the pathogenesis and genetics of Paget's disease of bone.

Authors:  Luigi Gennari; Domenico Rendina; Daniela Merlotti; Guido Cavati; Christian Mingiano; Roberta Cosso; Maria Materozzi; Filippo Pirrotta; Veronica Abate; Marco Calabrese; Alberto Falchetti
Journal:  Front Cell Dev Biol       Date:  2022-08-12

8.  CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis.

Authors:  Ya-Lang Huang; Szu-Ting Chen; Ren-Shyan Liu; Yen-Hsu Chen; Chun-Yu Lin; Chung-Hao Huang; Pei-Yun Shu; Ching-Len Liao; Shie-Liang Hsieh
Journal:  J Mol Med (Berl)       Date:  2016-03-31       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.